NATR on Nasdaq

Nature's Sunshine Products

Logo: Елена Лёвкина, Copyrighted free use, via Wikimedia Commons4

American nutritional supplements company

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.3 It employed 901 people in 2015.1 Its revenue was $325 million in 2015.1 Its shares trade on Nasdaq under the symbol NATR.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1972Founded1

Compare with Travere Therapeutics, Inc., BridgeBio or Zai Lab Limited, or pick any stock.

  • TickerNATR on Nasdaq1
  • Industryfood industry, personal care product1
  • HeadquartersLehi1
  • Websitewww.naturessunshine.com
  • Legal formpublic company1
  • Incorporated inUT5
  • Business address2901 West Bluegrass Blvd., Suite 100, Lehi, Ut 840485
  • Filer categoryAccelerated filer, Smaller reporting company5

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

72.4%Gross margin8
5.2%Operating margin8
4.1%Net margin8
5.7%Revenue growth, 20258
12.1%Return on equity8
$28.8MFree cash flow8

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

General health products brought in 40% of the revenue Nature's Sunshine Products broke down this way in fiscal 2025.

  1. General health products$192.1M840%up 4% from 2024
  2. Digestive products$124.4M826%up 11% from 2024
  3. Cardiovascular products$81.6M817%down 0% from 2024
  4. Immunity products$40.8M88%up 5% from 2024
  5. Personal Care Products$23.3M85%up 31% from 2024
  6. Weight management products$17.9M84%down 13% from 2024
  7. Shipping and Handling$2.5M81%up 19% from 2024
Products and services by year
Products and services20242025
General health products$183.9M$192.1M
Digestive products$111.7M$124.4M
Cardiovascular products$81.7M$81.6M
Immunity products$38.7M$40.8M
Personal Care Products$17.8M$23.3M
Weight management products$20.5M$17.9M
Shipping and Handling$2.1M$2.5M

Business segments

Asia brought in 46% of the revenue Nature's Sunshine Products broke down this way in fiscal 2025.

  1. Asia$221.8M846%up 7% from 2024
  2. North America$143.6M830%up 3% from 2024
  3. Europe$93.1M819%up 10% from 2024
  4. Latin america and other$21.6M85%down 6% from 2024
Business segments by year
Business segments20242025
Asia$207.8M$221.8M
North America$138.8M$143.6M
Europe$84.8M$93.1M
Latin america and other$22.9M$21.6M

Regions

Other Countries brought in 36% of the revenue Nature's Sunshine Products broke down this way in fiscal 2025.

  1. Other Countries$172.6M836%up 7% from 2024
  2. United States$133.4M828%up 4% from 2024
  3. Taiwan$67.3M814%down 5% from 2024
  4. Japan$56.1M812%up 28% from 2024
  5. South Korea$50.8M811%down 1% from 2024
Regions by year
Regions20242025
Other Countries$160.6M$172.6M
United States$127.9M$133.4M
Taiwan$70.6M$67.3M
Japan$43.9M$56.1M
South Korea$51.4M$50.8M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue28¢$132.4M
  • Research and development0¢$1.9M
  • Selling, general and admin37¢$178.4M
  • Other costs29¢$138.6M
  • Income tax2¢$9.4M
  • Profit4¢$19.5M

Out of $480.1M in revenue.8

Where each dollar of operating cash went, fiscal 2025

  • Capital spending18¢$6.5M
  • Share buybacks46¢$16.3M
  • Kept or used elsewhere35¢$12.5M

Out of $35.3M of cash from operations.8

Financial statements

Revenue9101112138$480.1M in 2025+33% since 2019
0$200.0M$400.0M$600.0M2019: $362.2M$362.2M20192020: $385.2M$385.2M2020+6%2021: $444.1M$444.1M2021+15%2022: $421.9M$421.9M2022−5%2023: $445.3M$445.3M2023+6%2024: $454.4M$454.4M2024+2%2025: $480.1M$480.1M2025+6%
Gross profit9101112138$347.7M in 2025+30% since 2019
0$100.0M$200.0M$300.0M$400.0M2019: $268.3M$268.3M20192020: $283.9M$283.9M2020+6%2021: $328.6M$328.6M2021+16%2022: $299.8M$299.8M2022−9%2023: $321.1M$321.1M2023+7%2024: $324.7M$324.7M2024+1%2025: $347.7M$347.7M2025+7%
Operating income9101112138$24.7M in 2025+53% since 2019
0$10.0M$20.0M$30.0M$40.0M2019: $16.1M$16.1M20192020: $21.5M$21.5M2020+33%2021: $34.7M$34.7M2021+61%2022: $16.3M$16.3M2022−53%2023: $18.7M$18.7M2023+15%2024: $20.1M$20.1M2024+7%2025: $24.7M$24.7M2025+23%
Net income9101112138$19.5M in 2025+182% since 2019
-$10.0M0$10.0M$20.0M$30.0M$40.0M2019: $6.9M$6.9M20192020: $23.0M$23.0M2020+231%2021: $30.2M$30.2M2021+32%2022: -$390.0K-$390.0K20222023: $15.1M$15.1M20232024: $7.7M$7.7M2024−49%2025: $19.5M$19.5M2025+154%
Fiscal year2019202020212022202320242025
Revenue$362.2M9$385.2M10$444.1M11$421.9M12$445.3M13$454.4M8$480.1M8
Cost of revenue$93.9M9$101.3M10$115.5M11$122.2M12$124.2M13$129.7M8$132.4M8
Gross profit$268.3M9$283.9M10$328.6M11$299.8M12$321.1M13$324.7M8$347.7M8
Research and development$2.1M9$1.5M10$1.4M11$1.5M12$1.6M13$1.7M8$1.9M8
Selling, general and admin$128.7M9$131.3M10$154.1M11$153.1M12$167.1M13$164.0M8$178.4M8
Operating income$16.1M9$21.5M10$34.7M11$16.3M12$18.7M13$20.1M8$24.7M8
Interest$43.0K9$102.0K10$250.0K11$249.0K12$69.0K12
Income before tax$31.8M11$15.2M12$20.2M13$18.4M8$29.8M8
Income tax$8.7M9-$137.0K10$1.6M11$14.7M12$3.8M13$10.5M8$9.4M8
Net income$6.9M9$23.0M10$30.2M11-$390.0K12$15.1M13$7.7M8$19.5M8
Earnings per share$0.359$1.0910$1.4511-$0.0212$0.7913$0.418$1.088
Earnings per share (diluted)$0.349$1.0710$1.4211-$0.0212$0.7713$0.408$1.068
Shares (weighted, basic)19.9M shares1119.3M shares1219.1M shares1318.6M shares818.0M shares8
Shares (weighted, diluted)20.3M shares1119.3M shares1219.5M shares1319.1M shares818.5M shares8

Compare Nature's Sunshine Products with another company

Corporate structure

Nature's Sunshine Products sits at the top of its group. 45 entities, 29 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Nature's Sunshine Products

  • Nature's Sunshine Products Lehi
    • NATR Distribution (M) SDN. BHD. Subsidiary · Malaysia
    • Nature's Sunshine Products de Colombia, S.A. Subsidiary · Colombia
    • Nature's Sunshine Products de El Salvador, S.A. C.V. Subsidiary · El Salvador
    • Nature's Sunshine Products de Mexico, S.A. de C.V. Subsidiary · Mexico
    • Nature's Sunshine Products de Venezuela, C.A. Subsidiary · Venezuela
    • Nature's Sunshine Products of Canada, Ltd. Subsidiary · Canada
    • Nature's Sunshine Produtos Naturais Ltda. Subsidiary · Brazil
    • Nature’s Sunshine (Far East) Limited Subsidiary · Hong Kong
    • Nature’s Sunshine (Hangzhou) Limited Subsidiary · China
    • Nature’s Sunshine Hong Kong Limited Subsidiary · Hong Kong
    • Nature’s Sunshine Marketing Ltda. Subsidiary · Brazil
    • Nature’s Sunshine Products de Honduras, S.A. de C.V. Subsidiary · Honduras
    • Nature’s Sunshine Products de Panamá, S.A. Subsidiary · Panama
    • Nature’s Sunshine Products del Ecuador, S.A. Subsidiary · Ecuador
    • Nature’s Sunshine Products Dominicana, S. R.L. Subsidiary · Dominican Republic
    • Nature’s Sunshine Products India Private Limited Subsidiary · India
    • Nature’s Sunshine Products International Distribution B.V. Subsidiary · Netherlands
    • Nature’s Sunshine Products of Russia, Inc. Subsidiary · Utah, United States
    • Nature’s Sunshine Products Poland sp. z.o.o. Subsidiary · Poland
    • NSP de Guatemala, S.A. Subsidiary · Guatemala
    • NSP Labs Inc Subsidiary · Utah, United States
    • Nutribiome Professional, Inc. Subsidiary · Utah, United States
    • PT Nature’s Sunshine Products Indonesia Subsidiary · Indonesia
    • PT Synergy Worldwide Subsidiary · Indonesia
    • Qemp Inc Subsidiary · Utah, United States
    • and 19 more

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Nature's Sunshine Products reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$141.1M8 Dec 31, 2025$137.4M8 Dec 31, 2024+2.7%
Accumulated depreciation$108.1M8 Dec 31, 2025$97.8M8 Dec 31, 2024+10.5%
Property and equipment, net$32.9M8 Dec 31, 2025$39.6M8 Dec 31, 2024−16.8%
Operating-lease assets (leased space)$17.6M8 Dec 31, 2025$12.8M8 Dec 31, 2024+37.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$93.9M8 Dec 31, 2025$84.7M8 Dec 31, 2024+10.9%

Inventory

ItemLatestA year beforeChange
Inventory, total$68.3M8 Dec 31, 2025$59.4M8 Dec 31, 2024+14.9%
Raw materials$22.9M8 Dec 31, 2025$21.3M8 Dec 31, 2024+7.4%
Work in process$1.3M8 Dec 31, 2025$1.0M8 Dec 31, 2024+23.7%
Finished goods$44.2M8 Dec 31, 2025$37.1M8 Dec 31, 2024+19.0%

Properties, in its own words

Our corporate and Synergy offices are located in a facility in Lehi, Utah, that consists of approximately 61,000 square feet. This facility is leased from an unaffiliated third-party through a lease agreement which expires in 2029.

We own our principal warehousing and manufacturing facilities housed in a building consisting of approximately 270,000 square feet and located on approximately 10 acres in Spanish Fork, Utah.

The rest of Item 2

We lease properties used primarily as distribution warehouses located in Georgia, Ohio, Texas and Utah, as well as offices and/or distribution warehouses in many of the countries in which we conduct business. For additional disclosure of leased properties, see Note 14, “Leases,” to our Consolidated Financial Statements, in Item 8, Part 2 of this report.

We believe that our current facilities are adequate for our business operations.

Item 2 of the 10-K filed Mar 10, 2026.16

The story

Nature's Sunshine was founded in 1972 by Gene and Kristine Hughes, who started encapsulating capsicum in their home kitchen. The company employs a multi-level marketing business model in which their products are primarily sold to the consumer by independent distributors who receive commissions based on their own sales, as well as sign-up bonuses and commissions based upon the sales of any distributors they may have recruited.

NSP also owns Synergy Worldwide, a multi-level marketing company that also sells nutritional supplements. Products for both companies are manufactured in a production and research facility located in Spanish Fork, Utah.

In June 2021, Nature’s Sunshine Products, Inc. and the David Eccles School of Business at the University of Utah partnered together to create a new scholarship. Nature’s Sunshine Products, Inc. partnered with the Opportunity Scholars program to provide full-ride scholarships to underrepresented students who are the first in their family to attend college.

Like similar multilevel marketing companies, Nature's Sunshine's business has been adversely affected by the lingering effects of the COVID-19 pandemic, global inflation and the Russian invasion of Ukraine. In the 4th quarter of 2022, net sales fell 13% to $103 million, as compared to the 4th quarter of 2021. According to CEO Terrence Moorehead, the company is making "strategic changes" and "redesigning processes and revamping sourcing relationships."

From Wikipedia’s article on Nature's Sunshine Products, shared under CC BY-SA 4.0.6

Leadership

Who has led Nature's Sunshine Products, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (49)

Subsidiaries and ownership

Subsidiaries

Subsidiaries (Exhibit 21)

  • NATR Distribution (M) SDN. BHD. Malaysia7
  • NSP Labs Inc Utah7
  • NSP de Guatemala, S.A. Guatemala7
  • Nature's Sunshine Products de Colombia, S.A. Colombia7
  • Nature's Sunshine Products de El Salvador, S.A. C.V. El Salvador7
  • Nature's Sunshine Products de Mexico, S.A. de C.V. Mexico7
  • Nature's Sunshine Products de Venezuela, C.A. Venezuela7
  • Nature's Sunshine Products of Canada, Ltd. Canada7
  • Nature's Sunshine Produtos Naturais Ltda. Brazil7
  • Nature’s Sunshine (Far East) Limited Hong Kong7
  • Nature’s Sunshine (Hangzhou) Limited China7
  • Nature’s Sunshine Hong Kong Limited Hong Kong7
  • Nature’s Sunshine Marketing Ltda. Brazil7
  • Nature’s Sunshine Products Dominicana, S. R.L. Dominican Republic7
  • Nature’s Sunshine Products India Private Limited India7
  • Nature’s Sunshine Products International Distribution B.V. Netherlands7
  • Nature’s Sunshine Products Poland sp. z.o.o. Poland7
  • Nature’s Sunshine Products de Honduras, S.A. de C.V. Honduras7
  • Nature’s Sunshine Products de Panamá, S.A. Panama7
  • Nature’s Sunshine Products del Ecuador, S.A. Ecuador7
  • Nature’s Sunshine Products of Russia, Inc. Utah7
  • Nutribiome Professional, Inc. Utah7
  • PT Nature’s Sunshine Products Indonesia Indonesia7
  • PT Synergy Worldwide Indonesia7
All 46 listed subsidiaries
  • Qemp Inc Utah7
  • Quality Nutrition International, LLC Utah7
  • Shanghai Nature’s Sunshine Health Products Trading Co. Ltd. China7
  • Synergy (Shanghai) Food Co., Ltd China7
  • Synergy Taiwan Taiwan7
  • Synergy Taiwan, Inc. Utah7
  • Synergy Vietnam Co., Ltd. Vietnam7
  • Synergy Worldwide (HK) Ltd. Hong Kong7
  • Synergy Worldwide (S) PTE Ltd. Singapore7
  • Synergy Worldwide Beauty and Health India Private Limited India7
  • Synergy Worldwide Europe B.V. Netherlands7
  • Synergy Worldwide Europe Management Services Spain S.L.U. Spain7
  • Synergy Worldwide Inc. Utah7
  • Synergy Worldwide Italy S.R.L. Italy7
  • Synergy Worldwide Japan G.K. Japan7
  • Synergy Worldwide Marketing (M) SDN BHD. Malaysia7
  • Synergy Worldwide Marketing (Thailand) Ltd. Thailand7
  • Synergy Worldwide Nutrition Products (Hong Kong) Hong Kong7
  • Synergy Worldwide Philippines Distribution, Inc. Philippines7
  • Synergy Worldwide Switzerland GmbH Switzerland7
  • Synergy Worldwide UK Ltd United Kingdom7
  • Synergy Worldwide, Inc. Philippines7

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Employees over time

  • 20159011

Timeline

  1. Aug 6, 20268-K Results of operations; Executive or director change79
  2. May 11, 20268-K Executive or director change80
  3. May 7, 20268-K Results of operations; Executive or director change; Shareholder vote81
  4. Mar 10, 20268-K Results of operations; Executive or director change82
  5. Nov 6, 20258-K Results of operations83
  6. Nov 5, 2025New chief executive Kenneth G. Romanzi becomes CEO17
  7. Oct 15, 20258-K Executive or director change; Regulation FD disclosure84
  8. Jul 31, 20258-K Results of operations85
  9. Jul 7, 20258-K Entered a material agreement86
  10. Jun 27, 20258-K Entered a material agreement87
  11. Jun 2, 20258-K Executive or director change; Other events88
  12. May 6, 20258-K Financial statements and exhibits89
  13. Mar 12, 20258-K Results of operations90
  14. Apr 3, 2019New chief executive Terrence Moorehead becomes CEO18
  15. Jan 16, 2015New chief executive David Wynne Roberts becomes CEO19
  16. May 9, 2013New chief executive Gregory Probert becomes CEO20
  17. Sep 27, 2011New chief executive Michael Dean becomes CEO21
  18. Jun 25, 2009Went public Listed on NASDAQ1
  19. Jan 11, 2007New chief executive Douglas Faggioli becomes CEO22
  20. 1972Founded Founded1

Calendar

Coming up

  1. Nov 5, 2026Reports results for the quarter ending Sep/202691

When it reported results

  1. Aug 6, 2026Reported quarterly or annual results79
  2. May 7, 2026Reported quarterly or annual results81
  3. Mar 10, 2026Reported quarterly or annual results82
  4. Nov 6, 2025Reported quarterly or annual results83
  5. Jul 31, 2025Reported quarterly or annual results85
  6. Mar 12, 2025Reported quarterly or annual results90
  7. Nov 7, 2024Reported quarterly or annual results92
  8. Aug 9, 2024Reported quarterly or annual results93

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

392 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 38 major events, 282 insider forms, 13 large holders, 39 other. The latest 20:

  1. Sep 15, 20264 EDGAR
  2. Sep 14, 20263 EDGAR
  3. Sep 3, 20264 EDGAR
  4. Aug 19, 20264 PRIMARY DOCUMENT EDGAR
  5. Aug 10, 20264 PRIMARY DOCUMENT EDGAR
  6. Aug 10, 2026SCHEDULE 13G/A EDGAR
  7. Aug 6, 202610-Q EDGAR
  8. Aug 6, 20268-K EDGAR
  9. Jun 29, 20264 EDGAR
  10. Jun 15, 20264 EDGAR
  11. Jun 11, 20264 EDGAR
  12. Jun 3, 20264 EDGAR
  13. May 22, 20264 EDGAR
  14. May 20, 20264 EDGAR
  15. May 19, 20264 EDGAR
  16. May 19, 20264 EDGAR
  17. May 19, 20264 EDGAR
  18. May 19, 20264 EDGAR
  19. May 19, 20264 EDGAR
  20. May 19, 20264 EDGAR

The 392 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

60 open-market trades by officers, directors and large owners since October 2021: 15 buys and 45 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 17, 2026FROHLICH PHIL10% ownerBuy20,000$14.69$293.8KForm 4
Aug 10, 2026PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerBuy40,876$15.84$647.5KForm 4
Aug 7, 2026PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerBuy96,000$16.63$1.6MForm 4
Aug 6, 2026PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerBuy4,513$16.57$74.8KForm 4
Jun 12, 2026Herbert Kevin R.EVP & President, North AmericaSale2,000$20.68$41.4KForm 4
Jun 5, 2026Yates Bryant JEVP & President, EuropeSale11,968$19.90$238.2KForm 4
Jun 1, 2026Norman Daniel CEVP & President, AsiaSale9,713$20.64$200.5KForm 4
May 21, 2026Brower Nathan GEVP, General CounselSale12,015$21.84$262.4KForm 4
Mar 13, 2026Yates Bryant JEVP & President, EuropeSale19,516$24.35$475.2KForm 4
Mar 13, 2026Norman Daniel CEVP & President, AsiaSale15,383$24.52$377.2KForm 4
Mar 13, 2026Lanoy Jonathan DavidSVP, Chief Accounting OfficerSale4,000$24.70$98.8KForm 4
Dec 12, 2025Yates Bryant JEVP & President, EuropeSale1,700$22.29$37.9KForm 4
Nov 18, 2025Lanoy Jonathan DavidSVP, Chief Accounting OfficerSale5,000$20.45$102.2KForm 4
Nov 14, 2025Brower Nathan GEVP, General CounselSale3,800$20.81$79.1KForm 4
Nov 12, 2025Norman Daniel CEVP & President, AsiaSale8,884$20.46$181.8KForm 4
Aug 29, 2025Yates Bryant JEVP & President, EuropeSale4,672$16.71$78.1KForm 4
Aug 26, 2025Yates Bryant JEVP & President, EuropeSale5,000$16.77$83.8KForm 4
Aug 13, 2025Lanoy Jonathan DavidSVP, Chief Accounting OfficerSale5,000$16.51$82.5KForm 4
Aug 13, 2025Brower Nathan GEVP, General CounselSale9,996$16.54$165.3KForm 4
Jun 27, 2025Fosun Pharma USA Inc.10% ownerSale2,854,607$11.46$32.7MForm 4

All 60 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Ken RomanziPresident and Chief Executive Officer66$107.9K$3.9M100
2025Terrence MooreheadFormer President and Chief Executive Officer$726.4K$3.6M100
2025Shane JonesExecutive Vice President, Chief Financial Officer$474.4K$1.7M100
2025Dan NormanExecutive Vice President, President Asia$441.7K$1.4M100
2024Terrence MooreheadFormer President and Chief Executive Officer$832.0K$2.9M100
2024Shane JonesExecutive Vice President, Chief Financial Officer$460.0K$1.2M100
2024Dan NormanExecutive Vice President, President Asia$425.0K$1.1M100
2023Terrence MooreheadFormer President and Chief Executive Officer$800.0K$3.5M100
2023Shane JonesExecutive Vice President, Chief Financial Officer$430.0K$1.5M100

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$5.4M 2020–2020
Money received by yearMoney received by year, 2020–2020: $5.4M in all. PPP loans $5.4M.$0$2M$4M$6M2020 · PPP loans: $5.4M2020
Figures by year
YearPPP loansTotal
2020$5.4M$5.4M

PPP loans

Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA101. Matched to this company by name and state.

  1. Apr 14, 2020$5.4M PPP loan (first draw) from Bank of America, National Association101To NATURE'S SUNSHINE PRODUCTS INC, Lehi UT; no forgiveness recorded

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Wynnefield Capital Inc2,473,686$53.9M37.1%No change
Prescott Group Capital Management, L.L.C.1,783,097$38.9M3.4%No change
BlackRock, Inc.989,020$21.6M0.0%−75,434
Dimensional Fund Advisors LP923,626$20.1M0.0%+28,189
American Century Companies Inc714,829$15.6M0.0%+140,004
Kennedy Capital Management LLC623,831$13.6M0.2%−67,667
Vanguard Capital Management LLC604,411$13.2M0.0%+7,578
Renaissance Technologies LLC527,568$11.5M0.0%−4,356
Geode Capital Management, LLC379,914$8.3M0.0%+7,365
Punch & Associates Investment Management, Inc.340,000$7.4M0.4%No change
State Street Corp326,890$7.1M0.0%+1,085
Hillsdale Investment Management Inc.304,607$6.6M0.2%−12,260
Vanguard Portfolio Management LLC289,408$6.3M0.0%+172,555
Boston Partners262,663$5.7M0.0%+42,470
Morgan Stanley235,491$5.1M0.0%−32,466
Jacobs Levy Equity Management, Inc214,189$4.7M0.0%+22,502
Nuveen, LLC208,892$4.6M0.0%+36,795
Bfsg, LLC198,861$4.3M0.4%+99,212
First Eagle Investment Management, LLC197,600$4.3M0.0%+98,800
Arrowstreet Capital, Limited Partnership191,251$4.2M0.0%+19,401
Jpmorgan Chase & Co187,784$4.0M0.0%+5,609
Mackenzie Financial Corp144,104$3.1M0.0%New
Two Sigma Investments, LP132,644$2.9M0.0%−23,692
Northern Trust Corp129,887$2.8M0.0%−2,637
Man Group plc126,873$2.8M0.0%+86,848

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Nature's Sunshine Products is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNATURES SUNSHINE PRODUCTS INC2
  • CIK0000275053
  • Employer ID (EIN)87-032798216
  • Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company16
  • Incorporated inUtah16
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance2
  • Business address2901 West Bluegrass Blvd., Suite 100, Lehi, UT 840482
  • Phone(801) 341-79002
  • Shares outstanding17,595,520 as of Jul 24, 202615
  • Public float$211.3M as of Jun 30, 202516
  • AuditorDeloitte & Touche LLP, Salt Lake City, Utah PCAOB ID 34; it also attests to the company’s internal control over financial reporting16
  • On EDGAR sinceMar 28, 19952
  • Filings1,462 in all: 4 (752), 8-K (205), 10-Q (89), SC 13G/A (71), 3 (62), DEF 14A (30), 10-K (23), SC 13G (20)2
    All 47 form types

    144 (19), UPLOAD (19), 11-K (18), SC 13D/A (16), CORRESP (15), DEFA14A (14), 4/A (10), 5 (10), 8-K/A (9), 10-K405 (8), S-8 (8), SC 13D (7), SC TO-I/A (7), NT 11-K (6), 10-K/A (5), EFFECT (3), NT 10-Q (3), PRE 14A (3), 10-12G/A (2), 3/A (2), 424B5 (2), 5/A (2), NT 10-K (2), S-3 (2), SC TO-I (2), SCHEDULE 13D/A (2), SCHEDULE 13G (2), 10-12G (1), 8-A12B (1), ARS (1), CERTNAS (1), DEFR14A (1), POS AM (1), PRER14A (1), REVOKED (1), S-3/A (1), S-8 POS (1), SC 14F1 (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Mar 10, 2026
    Quarterly report (10-Q) Aug 6, 2026
    Proxy statement (DEF 14A) Mar 27, 2026
    Latest 8-K (8-K) Aug 6, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, no par valueNATRNasdaq

From the cover page of the 10-K filed Mar 10, 2026 (Section 12(b) of the Exchange Act).16

Risk factors and legal proceedings

The risks Nature's Sunshine Products names in Item 1A of its 10-K filed Mar 10, 2026: 24 risks under these headings, as written.16

  • Regulatory and Litigation Risks
  • Our global operations are subject to numerous laws and regulations relating to trade restrictions and export controls and failure to comply with such rules could adversely affect our business.
  • Laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets.
  • Our products, business practices and manufacturing activities are subject to extensive government regulations and could be subject to additional laws and regulations.
  • Difficulties in registering our products for sale in foreign countries could have a material adverse effect on our results of operations and financial condition.
  • Our direct selling system could be challenged in one or more countries in which we do business.
  • If our independent consultants fail to comply with advertising laws, it could adversely affect our results of operations and financial condition.
  • Product liability claims could adversely affect our business.
  • We are subject to anti-bribery laws, including the Foreign Corrupt Practices Act.
  • Risks Related to Our Business
  • We may be unable to attract and retain independent consultants.
  • The loss of key independent consultants who have a significant sales networks could have a material adverse effect on our results of operations and financial condition.
The other 14 risks
  • Our business in China is subject to risks associated with integration, compliance, purchase price obligations, and general China-related laws and regulations.
  • Currency exchange rate fluctuations could adversely affect our results of operation and financial condition.
  • We could incur obligations resulting from the activities of our independent consultants.
  • We may be adversely affected by changes to our independent consultant compensation plans.
  • Geopolitical issues, conflicts and other global events could adversely affect our results of operations and financial condition.
  • Difficult economic conditions could adversely affect our results of operations and financial condition.
  • Our manufacturing activity is subject to certain risks.
  • Supply chain disruptions, manufacturing interruptions or delays or the failure to accurately forecast customer demand could adversely affect our ability to meet customer demand, lead to higher costs, or result in excess or obsolete inventory.
  • If we fail to timely and effectively obtain shipments of products from our suppliers and deliver products to our independent consultants and customers, our business and results of operations could be harmed.
  • Taxation and transfer pricing could adversely affect our results of operations and financial condition.
  • If we fail to maintain an effective system of internal controls, we may not be able to report our financial results accurately, may make a material misstatement in our financial statements, or may experience a financial loss. Any inability to report and file our financial results accurately and timely could harm our business and adversely affect the value of our business.
  • Risks Related to Our Use of Technology and Intellectual Property
  • Cybersecurity risks and the failure to maintain the integrity of data could expose us to data loss, litigation and liability, which could adversely affect our results of operations and financial condition.
  • The storage, processing and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations that could adversely affect our results of operation and financial condition.
  • System failures could adversely affect our results of operations and financial condition.

Legal proceedings

Our legal proceedings are discussed in Note 11, “Commitments and Contingencies,” to our Consolidated Financial Statements, in Item 8, Part 2 of this report.

The opening of Item 3, Legal Proceedings.16

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101